There are 2949 resources available
174P - Genomic testing, biomarkers and treatment patterns in early breast cancer
Presenter: Michael Method
Session: E-Poster Display
Resources:
Abstract
175P - Prognostic role of body mass index (BMI) in patients with Human Epidermal growth factor Receptor 2 (HER2)–positive early breast cancer treated with adjuvant trastuzumab-containing chemotherapy
Presenter: Francesca Ligorio
Session: E-Poster Display
Resources:
Abstract
176P - Germline mutation status and therapy response in patients with homologous recombination deficient, HER2-negative early breast cancer: Results of the GeparOLA study (NCT02789332)
Presenter: Jan Hauke
Session: E-Poster Display
Resources:
Abstract
177P - A plasma biomarker panel of microRNAs for early breast cancer diagnosis
Presenter: Shafiqa Siddique
Session: E-Poster Display
Resources:
Abstract
178P - HER2/neu 655 A>G polymorphism is associated with higher cardiotoxicity but not with less efficacy of trastuzumab, in HER2-positive breast cancer patients
Presenter: Isabel Blancas
Session: E-Poster Display
Resources:
Abstract
179P - Prognostic impact of body composition (BC) changes during neoadjuvant chemotherapy (NACT) in breast cancer patients (pts)
Presenter: Luisa Carbognin
Session: E-Poster Display
Resources:
Abstract
180P - Development of prognosis prediction model using cytokeratin 19 mRNA copy number of sentinel lymph node metastasis in breast cancer: A multicenter study in Japan
Presenter: daisuke yotsumoto
Session: E-Poster Display
Resources:
Abstract
181P - The use of Ki67 testing and scoring in HR+, HER2- early breast cancer
Presenter: Jacqueline Brown
Session: E-Poster Display
Resources:
Abstract
182P - Identification of a low-risk luminal breast cancer cohort that may not benefit from multi-gene testing
Presenter: Lei Lei
Session: E-Poster Display
Resources:
Abstract
183P - Prognostic value of high mesenchymal-epithelial transition factor gene (MET) expression in patients with estrogen receptor positive (ER+), human epidermal growth factor receptor negative (HER2-) early breast cancer
Presenter: Anna Diana
Session: E-Poster Display
Resources:
Abstract